These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1296614)

  • 1. Motor neuron disease model.
    Vrbová G; Greensmith L; Sieradzan K
    Nature; 1992 Nov; 360(6401):216. PubMed ID: 1296614
    [No Abstract]   [Full Text] [Related]  

  • 2. Histometric effects of ciliary neurotrophic factor in wobbler mouse motor neuron disease.
    Ikeda K; Wong V; Holmlund TH; Greene T; Cedarbaum JM; Lindsay RM; Mitsumoto H
    Ann Neurol; 1995 Jan; 37(1):47-54. PubMed ID: 7818257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic fibroblast growth factor has neuroprotective effects on axotomy-induced spinal motoneuron death and wobbler mouse motoneuron disease.
    Ikeda K; Kinoshita M; Iwasaki Y
    Muscle Nerve; 1996 Jun; 19(6):794-5. PubMed ID: 8609937
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic transfer of the wobbler gene to a C57BL/6J x NZB hybrid stock: natural history of the motor neuron disease and response to CNTF and BDNF cotreatment.
    Ishiyama T; Klinkosz B; Pioro EP; Mitsumoto H
    Exp Neurol; 1997 Nov; 148(1):247-55. PubMed ID: 9398466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease.
    Mitsumoto H; Ikeda K; Holmlund T; Greene T; Cedarbaum JM; Wong V; Lindsay RM
    Ann Neurol; 1994 Aug; 36(2):142-8. PubMed ID: 8053649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse.
    Bigini P; Atzori C; Fumagalli E; Cagnotto A; Barbera S; Migheli A; Mennini T
    Neurosci Lett; 2007 Oct; 426(2):106-10. PubMed ID: 17890007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current progress in the study on neurotrophic factors of motoneurons].
    Zhou M; Wu X; Ren F; Li M; Lu Y; Wang A; Yu W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):155-60. PubMed ID: 7656399
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease.
    Ikeda K; Klinkosz B; Greene T; Cedarbaum JM; Wong V; Lindsay RM; Mitsumoto H
    Ann Neurol; 1995 Apr; 37(4):505-11. PubMed ID: 7717687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.
    Dave KR; Raval AP; Purroy J; Kirkinezos IG; Moraes CT; Bradley WG; Pérez-Pinzón MA
    Neurobiol Dis; 2005 Feb; 18(1):126-33. PubMed ID: 15649703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of growth factors in the treatment of motor neuron diseases.
    Windebank AJ
    Adv Neurol; 1995; 68():229-34. PubMed ID: 8787234
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroprotective effect of cholinergic differentiation factor/leukemia inhibitory factor on wobbler murine motor neuron disease.
    Ikeda K; Iwasaki Y; Tagaya N; Shiojima T; Kinoshita M
    Muscle Nerve; 1995 Nov; 18(11):1344-7. PubMed ID: 7565937
    [No Abstract]   [Full Text] [Related]  

  • 12. Low intensity exercise attenuates disease progression and stimulates cell proliferation in the spinal cord of a mouse model with progressive motor neuronopathy.
    Ferrer-Alcon M; Winkler-Hirt C; Madani R; Perrin FE; Kato AC
    Neuroscience; 2008 Mar; 152(2):291-5. PubMed ID: 18295408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor neuron diseases. High hopes of a trophic factor.
    Oppenheim RW
    Nature; 1992 Aug; 358(6386):451-2. PubMed ID: 1641035
    [No Abstract]   [Full Text] [Related]  

  • 14. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy.
    Sendtner M; Schmalbruch H; Stöckli KA; Carroll P; Kreutzberg GW; Thoenen H
    Nature; 1992 Aug; 358(6386):502-4. PubMed ID: 1641039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder.
    Mennini T; Bigini P; Ravizza T; Vezzani A; Calvaresi N; Tortarolo M; Bendotti C
    J Neurosci Res; 2002 Nov; 70(4):553-60. PubMed ID: 12404509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated and widespread neuronal loss occurs in motor neuron degeneration (mnd) mice expressing a neurofilament-disrupting transgene.
    Plummer J; Peterson A; Messer A
    Mol Cell Neurosci; 1995 Dec; 6(6):532-43. PubMed ID: 8742270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for motor neuron disease.
    Green SL; Tolwani RJ
    Lab Anim Sci; 1999 Oct; 49(5):480-7. PubMed ID: 10551448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse.
    Schmitt-John T; Drepper C; Mussmann A; Hahn P; Kuhlmann M; Thiel C; Hafner M; Lengeling A; Heimann P; Jones JM; Meisler MH; Jockusch H
    Nat Genet; 2005 Nov; 37(11):1213-5. PubMed ID: 16244655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of the neurotrophins and neurotrophin-CNTF combinations in peripheral neuropathies and motor neuron diseases.
    Lindsay RM
    Ciba Found Symp; 1996; 196():39-48; discussion 48-53. PubMed ID: 8866127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mnd2: a new mouse model of inherited motor neuron disease.
    Jones JM; Albin RL; Feldman EL; Simin K; Schuster TG; Dunnick WA; Collins JT; Chrisp CE; Taylor BA; Meisler MH
    Genomics; 1993 Jun; 16(3):669-77. PubMed ID: 8325640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.